Bionano Genomics, Inc. Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 1 | -$1.01 | -$0.42 | -$0.64 |
Q2 2024 | 1 | -$0.65 | -$0.27 | -$0.42 |
Q3 2024 | 1 | -$0.31 | -$0.13 | -$0.20 |
Q4 2024 | 1 | -$0.21 | -$0.09 | -$0.13 |
Q1 2025 | 1 | -$0.15 | -$0.06 | -$0.10 |
Q2 2025 | 1 | -$0.13 | -$0.05 | -$0.08 |
Q3 2025 | 1 | -$0.10 | -$0.04 | -$0.07 |
Q4 2025 | 1 | -$0.10 | -$0.04 | -$0.07 |
Q1 2026 | 1 | -$0.13 | -$0.05 | -$0.08 |
Q2 2026 | 1 | -$0.11 | -$0.04 | -$0.07 |
Q3 2026 | 1 | -$0.08 | -$0.03 | -$0.05 |
Q4 2026 | 1 | -$0.08 | -$0.03 | -$0.05 |
Bionano Genomics, Inc. Earnings Date And Information
Bionano Genomics, Inc. last posted its earnings results on Wednesday, August 7th, 2024. The company reported $-0.24 earnings per share for the quarter, topping analysts' consensus estimates of $-0.42 by $0.18. The company had revenue of 6.07 M for the quarter and had revenue of 36.12 M for the year. Bionano Genomics, Inc. has generated $-7 earnings per share over the last year ($-6.81 diluted earnings per share) and currently has a price-to-earnings ratio of -0.14. Bionano Genomics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 3rd, 2025 based on prior year's report dates.
Bionano Genomics, Inc. Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/14/2024 | Q3 2024 | -$0.52 | $7.76 M | $6.07 M | ||
08/07/2024 | Q2 2024 | -$0.42 | -$0.24 | 0.18 | $8.02 M | $7.77 M |
05/08/2024 | Q1 2024 | -$0.64 | -$0.60 | 0.04 | $8.77 M | |
03/05/2024 | Q4 2023 | -$0.97 | -$0.96 | 0.01 | $10.72 M | |
11/08/2023 | Q3 2023 | -$0.75 | -$3.22 | -2.47 | $9.08 M | $9.32 M |
08/09/2023 | Q2 2023 | -$0.90 | -$1.24 | -0.34 | $8.29 M | $8.66 M |
05/09/2023 | Q1 2023 | -$0.90 | -$1.23 | -0.33 | $7.42 M | |
03/09/2023 | Q4 2022 | -$0.90 | -$1.30 | -0.4 | $8.22 M | |
11/03/2022 | Q3 2022 | -$1.20 | -$1.10 | 0.1 | $6.79 M | $7.22 M |
08/04/2022 | Q2 2022 | -$1.00 | -$1.13 | -0.13 | $6.28 M | $6.67 M |
05/05/2022 | Q1 2022 | -$0.80 | -$1.05 | -0.25 | $5.70 M | |
03/01/2022 | Q4 2021 | -$0.70 | -$0.81 | -0.11 | $6.30 M | |
11/04/2021 | Q3 2021 | -$0.60 | -$0.74 | -0.14 | $4.22 M | $4.66 M |
08/04/2021 | Q2 2021 | -$0.50 | -$0.70 | -0.2 | $3.50 M | $3.86 M |
05/13/2021 | Q1 2021 | -$0.50 | -$0.38 | 0.12 | $3.17 M | |
03/23/2021 | Q4 2020 | -$0.60 | -$1.13 | -0.53 | $3.99 M | |
11/12/2020 | Q3 2020 | -$0.60 | -$0.81 | -0.21 | $2.07 M | $2.20 M |
08/13/2020 | Q2 2020 | -$0.90 | -$0.89 | 0.01 | $863,000 | $1.18 M |
06/18/2020 | Q1 2020 | -$2.20 | -$2.95 | -0.75 | $1.14 M | |
03/10/2020 | Q4 2019 | -$2.83 | $2.79 M |
Bionano Genomics, Inc. Earnings: Frequently Asked Questions
-
When is Bionano Genomics, Inc.'s earnings date?
Bionano Genomics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 3rd, 2025 based off last year's report dates.
-
Did Bionano Genomics, Inc. beat their earnings estimates last quarter?
In the previous quarter, Bionano Genomics, Inc. (:BNGO) reported $-0.24 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.42 by $0.18.
-
How can I listen to Bionano Genomics, Inc.'s earnings conference call?
The conference call for Bionano Genomics, Inc.'s latest earnings report can be listened to online.
-
How can I read Bionano Genomics, Inc.'s conference call transcript?
The conference call transcript for Bionano Genomics, Inc.'s latest earnings report can be read online.
-
How much revenue does Bionano Genomics, Inc. generate each year?
Bionano Genomics, Inc. (:BNGO) has a recorded annual revenue of $36.12 M.
-
How much profit does Bionano Genomics, Inc. generate each year?
Bionano Genomics, Inc. (:BNGO) has a recorded net income of $36.12 M. Bionano Genomics, Inc. has generated $-6.81 earnings per share over the last four quarters.
-
What is Bionano Genomics, Inc.'s price-to-earnings ratio?
Bionano Genomics, Inc. (:BNGO) has a price-to-earnings ratio of -0.14 and price/earnings-to-growth ratio is -0.01.